Related Content
Aug. 20, 2026 — AliveCor has announced a new prospective cohort study (the M-KEEPS study) conducted by researchers at ...
August 24, 2026
April 15, 2026 – AliveCor has received CE Mark (Conformité Européenne) for the Kardia 12L electrocardiogram (ECG) System ...
April 15, 2026
Jan. 13, 2026 — AliveCor has received U.S. Food and Drug Administration (FDA) clearance for the next generation of KAI ...
January 14, 2026
Nov. 3, 2025 — GE HealthCare and AliveCor recently announced the world’s first clinical go-live of the integration ...
November 06, 2025
July 18, 2024 — AliveCor, a global leader in AI-powered cardiology, today announced that the American Medical ...
July 18, 2024
June 25, 2024 — AliveCor, the global leader in AI-powered cardiology, today announced the U.S. Food and Drug ...
June 25, 2024
July 21, 2023 — AliveCor, a leading innovator in FDA-cleared personal electrocardiogram (ECG) technology, today ...
July 21, 2023
June 19, 2023 — AliveCor, a global leader in personal electrocardiogram (ECG) technology, has announced a groundbreaking ...
June 19, 2023
December 26, 2022 — AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, today ...
December 26, 2022
April 4, 2022 – GE Healthcare and AliveCor have announced a partnership to deliver medical-grade six-lead ...
April 04, 2022